Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Blood Pressure Control After Endovascular Thrombectomy for Acute Embolic Stroke (INTENSE): a Multicentre, Open-label, Blinded-endpoint, Randomised Controlled Trial

NCT07350564 is registered in ClinicalTrials.gov with Hao Yonggang as lead sponsor.

NCT NCT07350564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07350564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Blood Pressure Control After Endovascular Thrombectomy for Acute Embolic Stroke (INTENSE): a Multicentre, Open-label, Blinded-endpoint, Randomised Controlled Trial
Lead sponsor
Hao Yonggang
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 31, 2028
Enrollment
910 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke